51 results
8-K/A
EX-99.1
RNAC
Cartesian Therapeutics Inc
23 Jan 24
Independent Auditor’s Report
4:05pm
the Black-Scholes option pricing model, based on the following range of assumptions:
Year Ended December 31,
Risk-free interest rate
Dividend yield
Expected
8-K/A
EX-99.2
wsek91v0 h1k4m
23 Jan 24
Independent Auditor’s Report
4:05pm
S-8
EX-99.2
ar0u9symr lrc9
12 Jan 24
Registration of securities for employees
4:16pm
8-K
EX-99.1
o7fvnc
18 Nov 22
November 2022 Selecta Biosciences Corporate Presentation SELB
4:30pm
8-K
EX-99.1
wit9g70e8 q6fpiyf0y
4 Aug 22
August 2022 Selecta Biosciences Corporate Presentation SELB
8:05am
DEFR14A
kehj3fwyqqlq4mo
3 May 22
Revised proxy
2:15pm